Back
Skye Bioscience Vs. Oramed Pharmaceuticals Industry Stock Comparison
Sell
12
SKYE
Skye Bioscience
Last Price:
$2.70
Seasonality Move:
59.61%
Sell
33
ORMP
Oramed Pharmaceuticals
Last Price:
$2.38
Seasonality Move:
6.43%
Sell
12
Skye Bioscience (SKYE)
is a Sell
Is Skye Bioscience a Buy, Sell or Hold?
-
The current Skye Bioscience [SKYE] share price is $2.72. The Score for SKYE is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
-
SKYE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
33
Oramed Pharmaceuticals (ORMP)
is a Sell
Is Oramed Pharmaceuticals a Buy, Sell or Hold?
-
The current Oramed Pharmaceuticals [ORMP] share price is $2.38. The Score for ORMP is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
ORMP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SKYE Stock Price Chart
What is Skye Bioscience's stock price today?
-
The Skye Bioscience share price today is $2.72Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SKYE is experiencing selling pressure, which indicates risk of future bearish movement.
ORMP Stock Price Chart
What is Oramed Pharmaceuticals's stock price today?
-
The Oramed Pharmaceuticals share price today is $2.38Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ORMP is experiencing selling pressure, which indicates risk of future bearish movement.
SKYE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.46 | Sell |
Relative Strength Index (14 RSI): | 25.62 | Sell |
Chaikin Money Flow: | -349443 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.3 - 4.42) | Sell |
Bollinger Bands (100): | (3.78 - 5.7) | Sell |
ORMP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 47.88 | Sell |
Chaikin Money Flow: | -83771 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.31 - 2.49) | Sell |
Bollinger Bands (100): | (2.31 - 2.45) | Sell |
SKYE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.18 | Sell |
20-day SMA: | 3.71 | Sell |
50-day SMA: | 4.43 | Sell |
200-day SMA: | 7.79 | Sell |
8-day EMA: | 3.15 | Sell |
20-day EMA: | 3.63 | Sell |
50-day EMA: | 4.24 | Sell |
200-day EMA: | 5.91 | Sell |
ORMP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.43 | Sell |
20-day SMA: | 2.43 | Sell |
50-day SMA: | 2.38 | Buy |
200-day SMA: | 2.43 | Sell |
8-day EMA: | 2.42 | Sell |
20-day EMA: | 2.42 | Sell |
50-day EMA: | 2.4 | Sell |
200-day EMA: | 2.49 | Sell |
Skye Bioscience Earnings Growth & SKYE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.55 per share, and a decrease next year of $0.26 per share.
Oramed Pharmaceuticals Earnings Growth & ORMP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.38 per share, and a decrease next year of $0.43 per share.
Skye Bioscience Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Oramed Pharmaceuticals Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |